Skip to content

Taperloc Complete Microplasty Stem

by Biomet Manufacturing Corp

510(k) K110400

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK110400 Date30 Sep 2011ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KWA
Device Class
Class III
Regulation
21 CFR Part 888.3330
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Taperloc Complete Microplasty Stem is a semi-constrained, uncemented acetabular component designed for hip arthroplasty. It is a porous-coated femoral stem intended for biological fixation in cementless hip replacements, providing stability and integration with the femoral bone.

This device is supplied in multiple sizes and offsets, including standard and shortened Microplasty stem lengths. It is classified as a Class III medical device under FDA regulations (K110400, KWA) and is intended for use in orthopedic surgical settings. The device is not described as sterile or single-use in the provided data, and no MRI safety information is specified.

Other devices from Biomet Manufacturing Corp

See all devices from Biomet Manufacturing Corp →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of hip replacements is the Taperloc Complete Microplasty Stem designed for, and how does it differ from other acetabular components?

    The Taperloc Complete Microplasty Stem is specifically designed for cementless hip arthroplasty, focusing on biological fixation with the femoral bone. It is a semi-constrained, uncemented acetabular component with a porous-coated femoral stem, which promotes integration and stability without the need for bone cement. This distinguishes it from cemented stems or fully constrained designs, as it relies on osseointegration for long-term stability.

  • Are there different sizes or offsets available for this device, and how might that affect my surgical planning?

    Yes, the Taperloc Complete Microplasty Stem is supplied in multiple sizes and offsets, including standard and shortened Microplasty stem lengths. This variability allows surgeons to select the appropriate fit for the patient’s anatomy, ensuring proper alignment and stability during hip replacement. The shortened lengths may be particularly useful for patients with limited femoral bone stock or specific anatomical constraints.

  • Is the Taperloc Complete Microplasty Stem intended for single-use or can it be reused in a clinical setting?

    The provided data does not explicitly state whether the Taperloc Complete Microplasty Stem is sterile or intended for single-use. However, as it is a porous-coated, uncemented implant, it is typically designed for single-patient use to maintain sterility and reduce infection risks. Reuse would require strict reprocessing protocols, which are not mentioned in the documentation, so it is safest to assume it is intended for single-use.

  • What regulatory pathway was followed for this device, and what does that mean for its use in clinical practice?

    The Taperloc Complete Microplasty Stem was cleared through the FDA 510(k) pathway, specifically under Traditional Review by the Orthopedic (OR) Advisory Committee. It was determined to be substantially equivalent to a legally marketed predicate device, meaning it meets FDA standards for safety and effectiveness as a Class III medical device for orthopedic use. This clearance allows it to be legally marketed and used in U.S. clinical settings for hip arthroplasty procedures.